Anna Volpe
Overview
Explore the profile of Anna Volpe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonifacio M, Genchi C, Lagioia A, Talamo V, Volpe A, Mariggio M
Int J Mol Sci
. 2022 Mar;
23(5).
PMID: 35269868
Drug-resistance monitoring is one of the hardest challenges in HIV management. Next-generation sequencing (NGS) technologies speed up the detection of drug resistance, allowing the adjustment of antiretroviral therapy and enhancing...
2.
Bavaro D, Laghetti P, Milano E, Brindicci G, Volpe A, Lagioia A, et al.
J Med Virol
. 2021 Feb;
93(5):3158-3164.
PMID: 33590900
Data regarding the immunological memory and long-time kinetics of immunoglobulin (IgG) against viral nucleoprotein (NP) and spike protein S1 receptor-binding domain (S1RBD) of Severe Acute Respiratory Syndrome-associated Coronavirus 2 (SARS-CoV-2)...
3.
Balena F, Bavaro D, Volpe A, Lagioia A, Angarano G, Monno L, et al.
J Med Virol
. 2020 Jul;
92(12):3271-3278.
PMID: 32609386
HIV-1 V2 domain binds α4β7, which assists lymphocyte homing to gut-associated lymphoid tissue. This triggers bacterial translocation, thus contributing to immune activation. We investigated whether variability of V2 binding site...
4.
Lepore L, Fabrizio C, Bavaro D, Milano E, Volpe A, Lagioia A, et al.
J Antimicrob Chemother
. 2020 Mar;
75(6):1580-1587.
PMID: 32191306
Objectives: Fostemsavir, a novel attachment inhibitor targeting the HIV-1 gp120, has demonstrated wide in vitro activity. However, the high rate of HIV gp120 substitutions could jeopardize its efficacy. We investigated...
5.
Di Cristo V, Adorni F, Maserati R, Lodi M, Bruno G, Maggi P, et al.
HIV Res Clin Pract
. 2020 Mar;
21(1):34-43.
PMID: 32129161
Antiretroviral therapies have been tested with the goal of maintaining virological suppression with a particular attention in limiting drug-related toxicity. With this aim we designed the DUAL study: a randomized,...
6.
Fabrizio C, De Gennaro N, Volpe A, Scudeller L, Lagioia A, Falasca K, et al.
J Clin Virol
. 2018 Nov;
109:45-49.
PMID: 30471517
Background And Objectives: We aimed to investigate to what extent a first-line DTG-based ART regimen reduces HIV-RNA in semen compared to plasma. Study Design: In this prospective, observational study, ART-naïve,...
7.
Maggi P, Bellacosa C, Leone A, Volpe A, Ricci E, Ladisa N, et al.
Atherosclerosis
. 2017 May;
263:398-404.
PMID: 28522147
Background And Aims: PREVALEAT (PREmature VAscular LEsions and Antiretroviral Therapy) II is a multicenter, longitudinal cohort study aimed at the evaluation of cardiovascular risk among advanced HIV-positive, treatment-naïve patients starting...
8.
Fasano M, Maggi P, Leone A, Volpe A, Fiore J, Angarano G, et al.
Dig Liver Dis
. 2017 Feb;
49(5):530-534.
PMID: 28179096
Background And Aim: Tenofovir disoproxil fumarate (TDF) is recommended as first-line monotherapy for nucleos(t)ide (NA)-naïve chronic hepatitis B (CHB) patients and as a second-line rescue therapy for NA-experienced patients with...
9.
Maggi P, Bruno G, Perilli F, Saracino A, Volpe A, Santoro C, et al.
In Vivo
. 2017 Jan;
31(1):125-131.
PMID: 28064231
Aim: To evaluate, in human immunodeficiency virus-hepatitis C virus co-infected patients, the impact of C-C chemokine receptor type 5 (CCR5) antagonist maraviroc-based antiretroviral therapy on the carotid intima media thickness...
10.
Brindicci G, Santoro C, Trillo G, Volpe A, Loconsole D, Monno L, et al.
Biomed Res Int
. 2016 Feb;
2016:9362708.
PMID: 26885522
Tuberculosis remains one of the major worldwide problems regarding public health. This study evaluates the burden of this disease in the BAT Province of the Apulia region (Italy); 12,295 patients...